Urgent recall for mushrooms over fears they can cause 'fatal infections'
Enoki mushrooms and a few kinds of sliced mushrooms sold in three states could be tainted with Listeria monocytogenes.
LLK Trading Inc on Sunday recalled 200-gram packages of its Needle Mushrooms, also known as Enoki mushrooms, that were sent to Bally Produce Corp in Maspeth, New York, and sold to Datang Supermarket Inc.
They are in plastic packaging that is clear on the top and blue at the bottom.
The nation's agency responsible for protecting the public health found listeria after doing routine testing of some packages. Product sales have stopped as the US Food and Drug Administration (FDA) and the company investigate how the contamination started.
There have not been any reports of customers becoming sick from eating the Enoki mushrooms, according to the announcement published by the FDA.
Customers should not eat them and return them for a full refund. Anyone with questions is urged to contact the company, which is based in Linden, New Jersey.
And on Friday, Wiet Peeters Farm Products Limited recalled its 227-gram packages of Aunt Mid's Fresh Sliced Mushrooms and Peeters Mushroom Farm Cremini Sliced Mushrooms, and 10-pound cardboard packages of Peeters Mushroom Farm Thick Slice Mushrooms.
Canadian Food Inspection Agency inspectors discovered listeria in the Fresh Sliced Mushrooms packages while testing the item, according to the FDA announcement. The two other products were manufactured on the same line. More Trending
The company based in Charing Cross Ontario, Canada, distributed the mushrooms to Michigan and Ohio. There have not been reports of people becoming ill, and customers with questions should contact Wiet Peeters Farm Products.
Listeria monocytogenes is 'an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems', according to the FDA.
It can cause pregnant women to have miscarriages or stillbirths. Healthy people can experience symptoms including diarrhoea, strong headaches, high fever, abdominal pain, nausea and stiffness.
The recalls come a couple of weeks after pre-made salads sold in eight US stated were recalled because they could contain cucumbers with salmonella.
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
MORE: Teddy bear 'made of human skin' sparks police investigation
MORE: Angry Trump fans burn their MAGA hats over Epstein files mystery
MORE: Trump gives Putin a 50-day deadline to stop war in Ukraine
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Herald Scotland
an hour ago
- The Herald Scotland
Judge scrubs Biden medical debt rule at Trump admin's request
The medical debt rule, finalized in January before former President Joe Biden left office, would've banned medical debt on credit reports and prohibited lenders from using a person's medical debt history to make lending decisions. The rule was scheduled to take effect in March, but the two trade groups sued the Consumer Financial Protection Bureau to halt the rule, and Jordan issued a stay, delaying the rule's start date. In late April, the Trump-appointed CFPB leadership opted not to oppose the lawsuit and filed a joint motion with the financial industry groups - the Consumer Data Industry Association and Cornerstone Credit Union League - to ask the judge to vacate the medical debt rule. Jordan, appointed during Trump's first administration, agreed with the trade groups that it was "fair, adequate and reasonable" to vacate the medical debt rule because it exceeded the CFPB's authority under the Fair Credit Reporting Act. Medical debt 'will likely get worse' Patricia Kelmar, senior director of health care campaigns at the U.S. PIRG Education Fund, said rule was necessary due to protect consumers from medical debt errors on credit reports. Medical bills accounted for more than half of debt collection on consumers' credit records, according to a 2022 report from the CFPB. "The problem is still here and will likely get worse," Kelmar said. "Medical debt on credit reports is disputed nearly three times as frequently as credit card debt." She said many of the 15 million Americans with medical debt on their credit reports are "penalized with lower credit scores, not because they owe the bill, but because they are still fighting it, or the hospitals reported it wrong." But industry groups cheered the decision. The medical debt rule would've potentially dealt lenders an "inaccurate and incomplete picture when making lending decisions," Dan Smith, president and CEO of the Consumer Data Industry Association, said in a statement. "Information about unpaid medical debts is an important element in assessing a consumer's ability to pay," Smith said. "This is the right outcome for protecting the integrity of the system." Paid medical debts, unpaid medical debts less than a year old and medical debts less than $500 already have been removed from credit reports by the three largest credit reporting companies. However, with the medical debt rule scrubbed, consumers can still expect larger medical debts to appear on credit reports. The decision comes as the Trump's sweeping tax cut and spending law could jeopardize health insurance coverage for millions of Americans in the coming years. The law would cut about $1 trillion from Medicaid and Affordable Care Act insurance plans, eliminating insurance coverage for 11.8 million people over the next decade, according to the nonpartisan Congressional Budget Office. Another 5 million could lose health insurance because the law doesn't extend Biden's COVID-19 pandemic-era tax credits that made ACA plans cheaper for consumers, according to a previous CBO analysis.
Daily Mail
12 hours ago
- Daily Mail
Urgent recall for popular yogurt brand over fears it contains shards of PLASTIC that could slice throats
Thousands of popular yogurt cups are being taken off shelves nationwide over fears they could contain one-inch shards of sharp plastic. All 17 flavors and sizes of YoCrunch, made by Danone, with toppings including granola, cookie dough, Oreo, M&M, Snickers and Twix pieces are being recalled. The Food and Drug Administration (FDA) found the plastic shards in the toppers that contain toppings and warned that they could pose a choking hazard or worse, slice a consumer's throat. The pieces are described as transparent, potentially with sharp edges, and between 0.2 and one-inch in size, or up to the size of a quarter. Several customers have contacted the FDA to report the plastic pieces, although no injuries or hospitalizations have been reported to date. Danone said the recall affected all its YoCrunch products on shelves, which were manufactured between May and early June and have a sell-by date of September this year. The company issued the recall on July 11, noting products were sold in many major retail chains, including Walmart, Target, Dollar General and Wegmans. Customers who have the products in refrigerators at home are advised not to consume them and to throw them out. They can contact the YoCrunch team for a refund. Consumers who suspect injury after consumption are urged to seek immediate medical care. In the release warning of the plastic pieces, the FDA said: 'These fragments pose a potential choking hazard, which is why we are taking immediate action to remove all affected products from store shelves.' Danone has said that a packaging error has led to the recall, after the plastics found in the topping pots were found to match the material used to mold the packaging. YoCrunch yogurts are heat-sealed at facilities in White Plains, New York, and Louisville, Colorado, the release said. The company's recall notice advises consumers to carefully check lot codes and expiration dates on YoCrunch products and contact their customer service hotline at 1-877-344-4886 for refunds or replacements. Customers can access a full list of the products involved in the recall on the FDA's website. It includes 6oz yogurt pots of strawberry and vanilla flavored yogurts with toppings including granola, M&Ms, Oreos and Snickers. And four packs of 4oz yogurts with a variety of toppings. Revealing the recall, the FDA classified it as Class II, its second highest risk level and meaning the product could cause temporary or reversible health consequences such as injury. And the side of a package of YoCrunch yogurts that are involved in the recall Although the plastic was limited to the toppers, the company opted to recall all variations of the product. The company said: 'Our top priority is ensuring the safety and quality of our products before they return to store shelves.' Danone North America, the parent company behind both the International Delight coffee creamer and YoCrunch yogurt brands, has faced multiple product recalls in recent months. Earlier this year, Danone voluntarily recalled more than 75,000 bottles of International Delight coffee creamers due to consumer reports of spoilage and illness. It also marked the third major recall this month involving a dangerous foreign object in packaged food. In June, Totally Cool Inc recalled over two dozen ice cream products, sold under brands like Friendly's, Hershey's, and Chipwich, after plastic and metal fragments were discovered inside the tubs. In another incident in May, a recall of packaged salads was announced by Fresh Farms Inc after metal fragments were found in some of their products. Industry observers say that the recent surge in recalls reflects pandemic-era supply chain challenges and the rapid adoption of automation, sometimes outpacing quality control improvements. A June 2025 report from the Institute of Food Technologists found a 15 percent increase in reported incidents involving plastic fragments in processed foods over the past three years, often linked to packaging equipment malfunctions or material defects. According to the Centers for Disease Control and Prevention (CDC), nearly one in six Americans contract a foodborne illness each year, resulting in about 128,000 hospitalizations and 3,000 deaths.
Daily Record
15 hours ago
- Daily Record
Scientists make Parkinson's breakthrough with new weekly injectable drug
Scientists have developed a new weekly injectable drug that could transform the lives of more than eight million people living with Parkinson's disease. The new treatment, which helps with muscle tremors, could potentially replace the need for multiple daily tablets, making life simpler and easier for those living with the condition. Scientists from the University of South Australia (UniSA) developed a long-acting injectable formulation that delivers a steady dose of levodopa and carbidopa - two key medications for Parkinson's - to last an entire week. The medication comes in the form of a biodegradable gel that can be injected under the skin or into muscle tissue, where it gradually releases the drugs over a week-long period. Parkinson's disease is the second most common neurological disorder, affecting more than 8.5 million people worldwide. There are approximately 13,000 people living with Parkinson's disease in Scotland, according to Parkinson's UK. Currently there is no cure, and the many symptoms of the condition, including tremors, rigidity and slow movement, are currently managed with pills that must be taken several times a day. But scientists believe the newly developed injection for Parkinson's could revolutionise how the disease is treated, and change the lives of those living with the condition. Lead researcher Professor Sanjay Garg, from UniSA's Centre for Pharmaceutical Innovation, said: "Our goal was to create a formulation that simplifies treatment, improves patient compliance, and maintains consistent therapeutic levels of medication. "This weekly injection could be a game-changer for Parkinson's care. Levodopa is the gold-standard therapy for Parkinson's, but its short life span means it must be taken several times a day." But the new drug can stop the constant hassle of taking multiple pills every day. The jab can maintain consistent plasma levels in the body by slowly releasing both levodopa and carbidopa steadily throughout the week, which also reduces the risks associated with fluctuating drug concentrations. UniSA PhD student Deepa Nakmode said: "After years of focused research, it's incredibly rewarding to see our innovation in long-acting injectables for Parkinson's disease reach this stage. Our invention has now been filed for an Australian patent." The injectable gel combines an FDA-approved biodegradable polymer named PLGA with Eudragit L-100, which is a pH-sensitive polymer. This ensures a controlled and sustained drug release into the body. Prof Garg concluded: "The implications of this research are profound. By reducing the frequency of dosing from multiple times a day to a weekly injection is a major step forward in Parkinson's therapy. "We're not just improving how the drug is delivered; we're improving patients' lives." The scientist says this new technology could also be adapted for other chronic conditions such as cancer, diabetes, neurodegenerative disorders, pain management, and chronic infections.
